Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot phase II study of oral sodium oxybate add-on therapy in DYT11 myoclonic dystonia
2006-001039-23Phase 2Completed
- Sponsor
- Carlo Besta Neurological Institute
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sodium oxybate in myoclonus dystonia (DYT11), sponsored by Carlo Besta Neurological Institute. Primary endpoints: Rate of responders and Total and single-item UMRS score change. Started Sep 2007; status: completed.
02
Drugs
sodium oxybate
03
Conditions
myoclonus dystonia (DYT11)
Beyond the preview
Go deeper on 2006-001039-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001039-23.